Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.38 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL794170 | 1.00 | SIRT2 (0.44) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3891843 | 0.98 | SIRT2 (0.44) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL23045026 | 0.95 | SIRT2 (0.43) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5334264 | 0.94 | SIRT2 (0.45) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| Phosphoric Acid SCHEMBL28738409 | 0.93 | SIRT2 (0.43) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL29544944 | 0.90 | SIRT2 (0.49) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL118552 | 0.90 | SIRT2 (0.49) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| Phosphoric Acid SCHEMBL28738408 | 0.89 | SIRT2 (0.44) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL333397 | 0.89 | SIRT2 (0.48) | SIRT2HDAC3HDAC4HDAC1HDAC7 | |
| Bromide SCHEMBL5514450 | 0.89 | SIRT2 (0.48) | SIRT2HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 557 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0929567-B1 | SOLID-PHASE PEPTIDE SYNTHESIS | ZEALAND PHARMA AS (DK) | 2005-03-02 | — | — | EP | claimed |
| US-12624068-B2 | Exon skipping by peptide nucleic acid derivatives | OLIPASS CORPORATION (KR) | 2026-05-12 | — | — | US | disclosed |
| EP-4731246-A2 | ALBUMIN BOUND MACROMOLECULE TRI-AGONIST ACTIVATING GLP-1/GIP/GLUCAGON RECEPTORS | AlbuNext, LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12576141-B2 | Albumin bound macromolecule tri-agonist activating GLP-1/GIP/glucagon receptors | AlbuNext, LLC (US) | 2026-03-17 | — | — | US | disclosed |
| EP-3319936-B1 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | HANGZHOU DAC BIOTECH CO LTD (CN) | 2025-12-17 | — | — | EP | disclosed |
| US-20250296958-A1 | GLYCOSYLATED CYCLIC ENDOMORPHIN ANALOGS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2025-09-25 | — | — | US | disclosed |
| US-20250223279-A1 | PROCESS FOR THE PREPARATION OF BELUMOSUDIL MESYLATE AND ITS CRYSTALLINE FORM | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-07-10 | — | — | US | disclosed |
| EP-4567028-A1 | PHTHALAZINONE DERIVATIVES AS NLRP3 INFLAMMASOME INHIBITORS | JANSSEN Pharmaceutica NV (BE) | 2025-06-11 | — | — | EP | disclosed |
| US-20250129118-A1 | MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE | H LEE MOFFITT CANCER CT & RES (US) | 2025-04-24 | — | — | US | disclosed |
| US-20250089717-A1 | FUNGICIDAL HALOMETHYL KETONES, HYDRATES AND ENOL ETHERS AND THEIR MIXTURES | FMC CORP (US) | 2025-03-20 | — | — | US | disclosed |
| WO-1996022391-A1 | ENCODED REACTION CASSETTE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1996-07-25 | — | — | WO | disclosed |
| WO-1996016980-A1 | MORPHOLINOETHYLAMIDE DERIVATIVES | NOVARTIS AG (CH) | 1996-06-06 | — | — | WO | disclosed |
| US-5430024-A | Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation | HOFFMANN-LA ROCHE INC. (US) | 1995-07-04 | — | — | US | disclosed |
| WO-1995017430-A1 | POLYCLONAL ANTIBODY TO PNA/NUCLEIC ACID COMPLEXES | DAKO A/S (DK) | 1995-06-29 | — | — | WO | disclosed |
| EP-0598806-A1 | SYNTHETIC STORAGE PROTEINS WITH DEFINED STRUCTURE CONTAINING PROGRAMMABLE LEVELS OF ESSENTIAL AMINO ACIDS FOR IMPROVEMENT OF THE NUTRITIONAL VALUE OF PLANTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-06-01 | — | — | EP | disclosed |
| US-5273982-A | An amidinoaryleneamidoalkylpiperazinyleneacetic acid | HOFFMANN-LA ROCHE INC. (US) | 1993-12-28 | — | — | US | disclosed |
| US-5233044-A | Pyrazolinone derivatives as self-indicating chromogens; monitoring coupling in peptide synthesis | MILLIPORE CORPORATION (US) | 1993-08-03 | — | — | US | disclosed |
| WO-1993003160-A1 | SYNTHETIC STORAGE PROTEINS WITH DEFINED STRUCTURE CONTAINING PROGRAMMABLE LEVELS OF ESSENTIAL AMINO ACIDS FOR IMPROVEMENT OF THE NUTRITIONAL VALUE OF PLANTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-02-18 | — | — | WO | disclosed |
| WO-1993000908-A1 | ELAM-1 RECEPTOR LIGANDS AS DIAGNOSTIC COMPOUNDS | ANTISOMA LIMITED (GB) | 1993-01-21 | — | — | WO | disclosed |
| EP-0472166-A1 | Tricyclic pyridone derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1992-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296958-A1 | GLYCOSYLATED CYCLIC ENDOMORPHIN ANALOGS | OPRD1, OGFR, OPRL1 | SIRT2 4651/4885HDAC3 2431/4885HDAC4 4433/4885 |
| US-12576141-B2 | Albumin bound macromolecule tri-agonist activating GLP-1/GIP/glucagon receptors | GLP1R, GCGR, GIPR | SIRT2 4551/4885HDAC3 4028/4885HDAC4 4583/4885 |
| US-12624068-B2 | Exon skipping by peptide nucleic acid derivatives | NSUN2, NSUN3, UPF1 | SIRT2 4452/4885HDAC3 4390/4885HDAC4 4251/4885 |
| US-20250223279-A1 | PROCESS FOR THE PREPARATION OF BELUMOSUDIL MESYLATE AND ITS CRYSTALLINE FORM | ROCK1, PDE5A, SQLE | SIRT2 3952/4885HDAC3 2638/4885HDAC4 1976/4885 |
| US-20250129118-A1 | MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE | MC1R, MC3R, MC5R | SIRT2 4341/4885HDAC3 3307/4885HDAC4 3850/4885 |
| US-20250089717-A1 | FUNGICIDAL HALOMETHYL KETONES, HYDRATES AND ENOL ETHERS AND THEIR MIXTURES | HCN2, CYP8B1, TUBA3C | SIRT2 930/4885HDAC3 331/4885HDAC4 902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.